Susan Podlogar - MetLife President

MET Stock  USD 73.92  0.86  1.18%   

President

Ms. Susan M. Podlogar is Chief Human Resource Officer, Executive Vice President of MetLife Inc, since July 10 2017. She comes to MetLife from Johnson Johnson, where she was Global Vice President of Human Resources for the company 21 billion Medical Devices business. In this role, she was responsible for driving the talent agenda to strengthen the company gotomarket model and help accelerate the pace of innovation. Previously, she was Vice President for Global Total Rewards and Performance, responsible for managing the development and execution of worldwide compensation, benefits, health resources, performance strategies and organizational analytics. Before joining JJ in 2003, Podlogar worked in human resources at Bayer Pharmaceuticals and Bristol Myers Squibb. She began her career in 1987 as a consultant with William M. Mercer, a global human resources consulting firm. since 2017.
Age 56
Tenure 7 years
Address 200 Park Avenue, New York, NY, United States, 10166-0188
Phone212 578 9500
Webhttps://www.metlife.com

MetLife Management Efficiency

Return On Equity is likely to gain to 0.09 in 2024, whereas Return On Capital Employed is likely to drop 0 in 2024. At this time, MetLife's Non Current Liabilities Total is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 5.4 B in 2024, whereas Total Current Liabilities is likely to drop slightly above 293.6 M in 2024. MetLife's management efficiency ratios could be used to measure how well MetLife manages its routine affairs as well as how well it operates its assets and liabilities.
The company has 18.83 B in debt with debt to equity (D/E) ratio of 4.11, demonstrating that the company may be unable to create cash to meet all of its financial commitments. MetLife has a current ratio of 1.09, demonstrating that it may not be capable to disburse its financial commitments when the payables are due. Debt can assist MetLife until it has trouble settling it off, either with new capital or with free cash flow. So, MetLife's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like MetLife sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for MetLife to invest in growth at high rates of return. When we think about MetLife's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

Larry PaulsonQualcomm Incorporated
58
Ruth PoratAlphabet Class C
66
Mary GendronQualcomm Incorporated
58
Derek AberleQualcomm Incorporated
45
James ThompsonQualcomm Incorporated
60
Todd McNealyAbacus Life
57
Matthew GrobQualcomm Incorporated
50
Erin PolekQualcomm Incorporated
49
Penny BaldwinQualcomm Incorporated
N/A
John MurphyQualcomm Incorporated
45
Sergey BrinAlphabet Class C
50
Cristiano AmonQualcomm Incorporated
54
Alex RogersQualcomm Incorporated
59
David DrummondAlphabet Class C
55
Matthew GanovskyAbacus Life
59
Kevin KirbyAbacus Life
57
Alexander RogersQualcomm Incorporated
67
Mauricio LopezHodoyanQualcomm Incorporated
N/A
Warren KneeshawQualcomm Incorporated
N/A
Brian ModoffQualcomm Incorporated
58
John SinnottQualcomm Incorporated
N/A
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York. Metlife operates under Insurance - General classification in the United States and is traded on New York Stock Exchange. MetLife (MET) is traded on New York Stock Exchange in USA. It is located in 200 Park Avenue, New York, NY, United States, 10166-0188 and employs 45,000 people. MetLife is listed under Life & Health Insurance category by Fama And French industry classification.

Management Performance

MetLife Leadership Team

Elected by the shareholders, the MetLife's board of directors comprises two types of representatives: MetLife inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MetLife. The board's role is to monitor MetLife's management team and ensure that shareholders' interests are well served. MetLife's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MetLife's outside directors are responsible for providing unbiased perspectives on the board's policies.
Catherine Kinney, Independent Director
Stephen Gauster, Senior Vice President Interim General Counsel
Michel Khalaf, President, Chief Executive Officer, Director
Bill Pappas, Executive Vice President Head of Global Technology and Operations
Diana McKenzie, Independent Director
Randy Stram, Senior Benefits
Cheryl Grise, Lead Independent Director
Maria Morris, Executive Vice President Head - Global Employee Benefits
Edward Spehar, Executive Vice President Treasurer
Kenton Sicchitano, Independent Director
John Hall, Senior Relations
John Hele, CFO and Executive VP
David Herzog, Independent Director
Graham Cox, Head of Retirement and Income Solutions
Robin Gordon, Chief Data and Analytics Officer
Randy Clerihue, Chief Communications Officer
Gerald Hassell, Independent Director
Tamara Schock, Executive Vice President Chief Accounting Officer
Steven Kandarian, Chairman of the Board and Presidentident, CEO
Jennifer Gottlieb, Head - Global Employee Communication
Ed Spehar, Executive Vice President Treasurer
Michael Farrell, Head EVP
Denise Morrison, Independent Director
Nuria Garcia, Head of EMEA
Christopher Townsend, President of Asia
Ricardo Anzaldua, Executive Vice President General Counsel
Mark Weinberger, Independent Director
Glenn Hubbard, Lead Independent Director
John McCallion, Chief Financial Officer, Executive Vice President
Kishore Ponnavolu, President - Asia Region
Randolph Clerihue, Chief Officer
Carlos Gutierrez, Independent Director
Michael Roberts, Executive Vice President Chief Marketing Officer
Pawan Verma, Executive Vice President, Chief Information Officer
Martin Lippert, Executive VP of Global Technology and Operations
Lyndon Oliver, Executive Vice President Treasurer
Ramy Tadros, Executive Vice President and President - U.S. Business
Alfred Kelly, Independent Director
William ODonnell, Executive Vice President Chief Accounting Officer
Susan MBA, Executive Officer
Robert Hubbard, Independent Chairman of the Board
William Kennard, Independent Director
Steven Goulart, Executive Vice President, Chief Investment Officer
Susan Podlogar, Chief Human Resource Officer, Executive Vice President
Robert Merck, Global MD
Cindy Pace, Global Chief Diversity and Inclusion Officer
William Moore, President Business
James Kilts, Independent Director
Esther Lee, Executive Vice President Global Chief Marketing Officer
Edward Kelly, Independent Director
Oscar Schmidt, President of Latin America
Frans Hijkoop, Chief Human Resource Officer, Executive Vice President
Marlene Debel, Executive Vice President, Chief Risk Officer
Lulu Wang, Independent Director
Timothy Ring, Chief Sustainability Officer
John CPA, Executive CFO

MetLife Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is MetLife a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether MetLife is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if MetLife Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Metlife Stock. Highlighted below are key reports to facilitate an investment decision about Metlife Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MetLife. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For more information on how to buy MetLife Stock please use our How to Invest in MetLife guide.
Note that the MetLife information on this page should be used as a complementary analysis to other MetLife's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Complementary Tools for MetLife Stock analysis

When running MetLife's price analysis, check to measure MetLife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MetLife is operating at the current time. Most of MetLife's value examination focuses on studying past and present price action to predict the probability of MetLife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MetLife's price. Additionally, you may evaluate how the addition of MetLife to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Stocks Directory
Find actively traded stocks across global markets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Is MetLife's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MetLife. If investors know MetLife will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MetLife listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.61)
Dividend Share
2.06
Earnings Share
1.81
Revenue Per Share
88.295
Quarterly Revenue Growth
0.219
The market value of MetLife is measured differently than its book value, which is the value of MetLife that is recorded on the company's balance sheet. Investors also form their own opinion of MetLife's value that differs from its market value or its book value, called intrinsic value, which is MetLife's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MetLife's market value can be influenced by many factors that don't directly affect MetLife's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MetLife's value and its price as these two are different measures arrived at by different means. Investors typically determine if MetLife is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MetLife's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.